Matinas BioPharma Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Formation and Reverse Acquisition of Matinas BioPharma Holdings - Formation (Details Textual)

Formation and Reverse Acquisition of Matinas BioPharma Holdings - Formation (Details Textual) (USD $)	1 Months Ended	12 Months Ended
	May 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	7,500,000
Warrants Issued For Purchase Of Common Stock	3,750,000
Common Stock To Be Issued Upon Exercise Of Warrants	3,750,000
Investment Warrants, Exercise Price	$ 2.00invest_InvestmentWarrantsExercisePrice
Proceeds from Issuance of Warrants	$ 375,000us-gaap_ProceedsFromIssuanceOfWarrants	$ 0us-gaap_ProceedsFromIssuanceOfWarrants	$ 10,000us-gaap_ProceedsFromIssuanceOfWarrants
Stock And Warrants Issued, Price Per Unit	0.10mtnb_StockAndWarrantsIssuedPricePerUnit
Proceeds from Issuance of Common Stock		0	15,000,000
Adam Stern And Entities Owned By Stern [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	2,000,000
Common Stock To Be Issued Upon Exercise Of Warrants	1,000,000
Proceeds from Issuance or Sale of Equity, Total	375,000
Third Parties Including Certain Representatives Of Aegis Capital Corp [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	5,500,000
Warrants Issued For Purchase Of Common Stock	2,250,000
Common Stock To Be Issued Upon Exercise Of Warrants	2,250,000
Proceeds from Issuance of Warrants	75,000
Proceeds from Issuance or Sale of Equity, Total	375,000
Proceeds from Issuance of Common Stock	300,000
Formation Warrants [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	250,000
Warrants Issued For Purchase Of Common Stock	250,000
Investment Warrants, Exercise Price	$ 2.00
Proceeds from Issuance or Sale of Equity, Total	10,000
Issuance Of Warrants Below Fair Value, Lower Price Than Fair Value Per Warrant	0.47
Issuance Of Equity Instruments Below Fair Value	$ 108,316
Warrants Purchase Price	0.04